Albano L et al. |
OSAKA trial: a randomized, controlled trial comparing tacrolimus QD and BD in kidney transplantation. |
2013 |
Transplantation |
pmid:23982340
|
Therapondos G et al. |
Cardiac hypertrophy in liver transplant recipients: tacrolimus, cyclosporine or both? |
2003 |
Transplantation |
pmid:12883220
|
Marcos A et al. |
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. |
2004 |
Transplantation |
pmid:15480160
|
Heeckt PF et al. |
Functional impairment of enteric smooth muscle and nerves caused by chronic intestinal allograft rejection regresses after FK506 rescue. |
1995 |
Transplantation |
pmid:7530870
|
Gruessner RW et al. |
A prospective study of FK506 versus CsA and pig ATG in a porcine model of small bowel transplantation. |
1995 |
Transplantation |
pmid:7530871
|
Jindal RM et al. |
Serum lipid changes in liver transplant recipients in a prospective trial of cyclosporine versus FK506. |
1994 |
Transplantation |
pmid:7514317
|
Boleslawski E et al. |
Defective inhibition of peripheral CD8+ T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection. |
2004 |
Transplantation |
pmid:15223897
|
Wozniak LJ et al. |
Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation. |
2015 |
Transplantation |
pmid:26038872
|
Kuypers DR et al. |
Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: the need for true drug exposure measurements. |
2010 |
Transplantation |
pmid:20555228
|
Guethoff S et al. |
Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation. |
2013 |
Transplantation |
pmid:23423270
|
Bilolo KK et al. |
Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat. |
2003 |
Transplantation |
pmid:12811249
|
Hoffman AL et al. |
The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. |
1990 |
Transplantation |
pmid:1690469
|
Miyakoshi S et al. |
Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases. |
2007 |
Transplantation |
pmid:17700155
|
Huang E et al. |
Alemtuzumab induction in deceased donor kidney transplantation. |
2007 |
Transplantation |
pmid:17984833
|
Jain A et al. |
Delayed introduction of tacrolimus postliver transplant with intravenous mycophenolate mofetil preserves renal function without incurring rejection. |
2014 |
Transplantation |
pmid:25285953
|
Cox KL et al. |
An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. |
1995 |
Transplantation |
pmid:7533344
|
Yanchar NL et al. |
Tacrolimus (FK506)--its effects on intestinal glucose transport. |
1996 |
Transplantation |
pmid:8610392
|
Solez K et al. |
Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. |
1998 |
Transplantation |
pmid:9884269
|
Reyes J et al. |
Expressive dysphasia possibly related to FK506 in two liver transplant recipients. |
1990 |
Transplantation |
pmid:1701571
|
Ciancio G et al. |
Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplantation with tacrolimus and steroid avoidance: four-year analysis. |
2011 |
Transplantation |
pmid:21107305
|
Squifflet JP et al. |
Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients. |
2001 |
Transplantation |
pmid:11468536
|
Theruvath TP et al. |
Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. |
2001 |
Transplantation |
pmid:11468538
|
Jurcevic S et al. |
A new enzyme-linked immunosorbent assay to measure anti-endothelial antibodies after cardiac transplantation demonstrates greater inhibition of antibody formation by tacrolimus compared with cyclosporine. |
1998 |
Transplantation |
pmid:9603168
|
Kung L and Halloran PF |
Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrations. |
2000 |
Transplantation |
pmid:10933159
|
Beatty PR et al. |
Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines. |
1998 |
Transplantation |
pmid:9603175
|
Arzouk N et al. |
Interaction between tacrolimus and fumagillin in two kidney transplant recipients. |
2006 |
Transplantation |
pmid:16421493
|
Zervos XA et al. |
Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation. |
1998 |
Transplantation |
pmid:9583863
|
Maes BD et al. |
Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporine. |
1999 |
Transplantation |
pmid:10589943
|
Shapiro AM et al. |
Defining optimal immunosuppression for islet transplantation based on reduced diabetogenicity in canine islet autografts. |
2002 |
Transplantation |
pmid:12490784
|
Mehra MR et al. |
Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression. |
2002 |
Transplantation |
pmid:12490790
|
First MR et al. |
New-onset diabetes after transplantation (NODAT): an evaluation of definitions in clinical trials. |
2013 |
Transplantation |
pmid:23619735
|
Woodle ES et al. |
FK506: inhibition of humoral mechanisms of hepatic allograft rejection. |
1992 |
Transplantation |
pmid:1379749
|
Taler SJ et al. |
Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine. |
1996 |
Transplantation |
pmid:8970613
|
Naesens M et al. |
Maturation of dose-corrected tacrolimus predose trough levels in pediatric kidney allograft recipients. |
2008 |
Transplantation |
pmid:18431234
|
Dean PG et al. |
Kidney transplant histology after one year of continuous therapy with sirolimus compared with tacrolimus. |
2008 |
Transplantation |
pmid:18431244
|
Shoji T et al. |
Operational tolerance to class I disparate lungs can be induced despite pretransplant immunization with class I allopeptides. |
2007 |
Transplantation |
pmid:18091523
|
Nguyen L et al. |
Conversion from tacrolimus/mycophenolic acid to tacrolimus/leflunomide to treat cutaneous warts in a series of four pediatric renal allograft recipients. |
2012 |
Transplantation |
pmid:22960763
|
Thomas PG et al. |
Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation. |
2007 |
Transplantation |
pmid:17565326
|
Shapiro R et al. |
Tacrolimus in pediatric renal transplantation. |
1996 |
Transplantation |
pmid:8990356
|
Przepiorka D et al. |
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus. |
1996 |
Transplantation |
pmid:8990368
|
Wissing KM et al. |
Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation. |
2006 |
Transplantation |
pmid:17006324
|
Stratta RJ et al. |
Does surgical technique influence outcomes after simultaneous kidney-pancreas transplantation? |
2004 |
Transplant. Proc. |
pmid:15194373
|
Mastrobuoni S et al. |
Two-dose daclizumab, tacrolimus, mycophenolate mofetil, and steroid-free regimen in de novo cardiac transplant recipients: early experience. |
2007 |
Transplant. Proc. |
pmid:17889125
|
Jordan ML et al. |
Tacrolimus for rescue of refractory renal allograft rejection. |
1998 |
Transplant. Proc. |
pmid:9636511
|
Kotowski M et al. |
The Importance of New Generation Sequencing (NGS) HLA Typing in Renal Transplantation-Preliminary Report. |
|
Transplant. Proc. |
pmid:29937294
|
Jun H et al. |
Experiences on conversion to once-daily Advagraf and sirolimus combination in stable kidney recipients. |
2014 |
Transplant. Proc. |
pmid:24655973
|
Balda S et al. |
Combination of everolimus and tacrolimus in kidney transplant patients with intolerance to mycophenolate mofetil/mycophenolic acid. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715841
|
Morris RE et al. |
Comparative immunopharmacologic effects of FK 506 and CyA in in vivo models of organ transplantation. |
1990 |
Transplant. Proc. |
pmid:1689885
|
Gunji Y et al. |
Pathologic characteristics of vasculitis in renal transplant recipient dogs receiving immunosuppressive agents, FK 506, rapamycin, or RS-61443. |
1993 |
Transplant. Proc. |
pmid:7679841
|
Jain AB et al. |
Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK 506. |
1991 |
Transplant. Proc. |
pmid:1721274
|
Namii Y et al. |
Tetrahydropyranyladriamycin with FK 506 combination therapy for hamster-to-rat-concordant xenotransplantation. |
1996 |
Transplant. Proc. |
pmid:8623358
|
Cai TH et al. |
Improved immunosuppression with combination tacrolimus (FK506) and mycophenolic acid in orthotopic liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636572
|
Kim HC and Park SB |
Mycophenolate mofetil-induced ischemic colitis. |
2000 |
Transplant. Proc. |
pmid:11119990
|
Rodrigo E et al. |
Higher initial tacrolimus blood levels and concentration-dose ratios in kidney transplant recipients who develop diabetes mellitus. |
2005 |
Transplant. Proc. |
pmid:16386549
|
Rosborough SL et al. |
Identification of FKBP-related proteins with antibodies of predetermined specificity and isolation by FK 506 affinity chromatography. |
1991 |
Transplant. Proc. |
pmid:1721306
|
Tryphonopoulos P et al. |
The impact of Campath 1H induction in adult liver allotransplantation. |
2005 |
Transplant. Proc. |
pmid:15848669
|
Daly I et al. |
Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus. |
2002 |
Transplant. Proc. |
pmid:12176458
|
Takaori K et al. |
Basic study on immunologic effects of cyclosporine and FK 506 for application to pancreatic transplantation. |
1992 |
Transplant. Proc. |
pmid:1376531
|
Kuroki H and Ikuta Y |
Nerve regeneration of vascularized rat limb allograft and functional recovery of long-term graft survivals treated by short course of FK 506 or cyclosporine. |
1995 |
Transplant. Proc. |
pmid:7533405
|
Shaw BW et al. |
FK 506 for rescue treatment of acute and chronic rejection in liver allograft recipients. |
1991 |
Transplant. Proc. |
pmid:1721338
|
Pascual J et al. |
Mycophenolate mofetil tolerability and dose changes in tacrolimus-treated renal allograft recipients. |
2006 |
Transplant. Proc. |
pmid:17097946
|
Krämer BK et al. |
Steroid withdrawal or steroid avoidance in renal transplant recipients: focus on tacrolimus-based immunosuppressive regimens. |
2005 |
Transplant. Proc. |
pmid:15919467
|
Kahan BD |
Current approaches to the use of sirolimus in renal transplantation. |
2009 |
Transplant. Proc. |
pmid:19857664
|
Sano N et al. |
Oral FK 506 blood levels are elevated in pig short bowel model: further investigations with co-administration of an intestinal CYP3A4 inhibitor. |
2002 |
Transplant. Proc. |
pmid:12034301
|
Choong CL et al. |
Dose-Response Relationship Between Diltiazem and Tacrolimus and Its Safety in Renal Transplant Recipients. |
2018 |
Transplant. Proc. |
pmid:30316389
|
Shu KH et al. |
A multicenter trial of FK506 as rescue therapy for renal transplant recipients in Taiwan. |
1998 |
Transplant. Proc. |
pmid:9838570
|
Fries D et al. |
Development of renal dysfunction and renal histological lesions in two patients treated with FK 506 for acute rejection following liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721370
|
Jain AB et al. |
Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. |
1991 |
Transplant. Proc. |
pmid:1703354
|
Bennett WM |
Renal complications after heart transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083019
|
Tsuchida T et al. |
The development of humanized liver with Rag1 knockout rats. |
2014 |
Transplant. Proc. |
pmid:24815157
|
Espà A et al. |
Influence of hepatic ischemia-reperfusion injury on tacrolimus acute renal toxicity in pigs. |
2002 |
Transplant. Proc. |
pmid:12493373
|
Aumente Rubio MD et al. |
Clinical pharmacokinetics of tacrolimus in heart transplantation: new strategies of monitoring. |
2003 |
Transplant. Proc. |
pmid:12962871
|
Ko S et al. |
Predominant role of local immunosuppressive effect in enhanced efficacy of liposomal FK506 in organ transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123117
|
Rao AS et al. |
Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. |
1996 |
Transplant. Proc. |
pmid:8908140
|
Gurkan A et al. |
Comparison of tacrolimus and neoral-based immunosuppressive regimens in renal transplantation patients: singles-center experience. |
2002 |
Transplant. Proc. |
pmid:12176525
|
Arita S et al. |
Effect of FK 506 in experimental pancreas transplantation. |
1995 |
Transplant. Proc. |
pmid:7536980
|
Elinav H et al. |
Plasma oxidizability and plasma carbonyls, markers of oxidative stress, in liver transplant patients. |
2001 |
Transplant. Proc. |
pmid:11543789
|
Viebahn R et al. |
Hypoxic and reoxygenation injury in human and rat hepatocytes--influence of FK 506 and cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1721401
|
Sato K et al. |
Effectiveness of triple drug immunosuppression for pancreaticoduodenal allotransplantation in dogs. |
1992 |
Transplant. Proc. |
pmid:1379753
|
Masaki Y et al. |
Microchimerism and rat small bowel transplantation combined with donor-type bone marrow cells. |
1996 |
Transplant. Proc. |
pmid:8769154
|
Opelz G |
Immunosuppression with FK 506 does not improve kidney graft survival. Collaborative Transplant Study. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083513
|
Murphy MP and Morris RE |
Brequinar sodium effectively and potently suppresses allograft rejection in a heterotopic mouse heart transplant model. |
1993 |
Transplant. Proc. |
pmid:7685955
|
Kobayashi C et al. |
Suppression of corneal graft rejection in rabbits by a new immunosuppressive agent, FK-506. |
1989 |
Transplant. Proc. |
pmid:2468254
|
Carbajal R et al. |
Case report: boldo (Peumus boldus) and tacrolimus interaction in a renal transplant patient. |
2014 |
Transplant. Proc. |
pmid:24981811
|
Troppmann C et al. |
FK 506 versus cyclosporine A for steroid-free synergistic combination therapy with rapamycin in a discordant large animal donor xenoislet transplant model. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123585
|
Glanemann M et al. |
Mycophenolate mofetil is superior in combination with tacrolimus compared to cyclosporine for immunosuppressive therapy after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267194
|
Wu GD et al. |
FK 506 inhibits the development of transplant arteriosclerosis. |
1991 |
Transplant. Proc. |
pmid:1721433
|
Todo S et al. |
Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. |
1987 |
Transplant. Proc. |
pmid:2445076
|
Kohnle M et al. |
Conversion to tacrolimus in cyclosporin A treated patients with gum hyperplasia. |
1998 |
Transplant. Proc. |
pmid:9723413
|
Slatinska J et al. |
Long-term follow-up of stable kidney transplant recipients after conversion from tacrolimus twice daily immediate release to tacrolimus once-daily prolonged release: a large single-center experience. |
2013 |
Transplant. Proc. |
pmid:23726604
|
Alessiani M et al. |
Effect of perioperative donor bone marrow infusion after small bowel transplantation in swine: preliminary results. |
1998 |
Transplant. Proc. |
pmid:9745496
|
Jelassi ML et al. |
Therapeutic drug monitoring in de novo kidney transplant receiving the modified-release once-daily tacrolimus. |
2011 |
Transplant. Proc. |
pmid:21440742
|
Arikan C et al. |
Allergic disease after pediatric liver transplantation with systemic tacrolimus and cyclosporine a therapy. |
2003 |
Transplant. Proc. |
pmid:14697973
|
Lautenschlager I et al. |
Efficiency of FK 506 and CyA to prevent acute cellular rejection of pig liver allografts. |
1991 |
Transplant. Proc. |
pmid:1714650
|
Ikeda M et al. |
Successful Second Allogeneic Stem Cell Transplantation From a Sibling Donor for Relapse of Myelodysplastic Syndrome in a Recipient of a Renal Transplant From His Mother: Case Report. |
2016 |
Transplant. Proc. |
pmid:27932152
|
Filler G |
Optimization of immunosuppressive drug monitoring in children. |
2007 |
Transplant. Proc. |
pmid:17524944
|
Guleria S et al. |
Tacrolimus (Pan Graf) in live related renal transplantation: an initial experience of 101 recipients in India. |
2007 |
Transplant. Proc. |
pmid:17445588
|
Groth CG |
Immunosuppressive regimens of tomorrow. |
1995 |
Transplant. Proc. |
pmid:8539797
|
Lawen J et al. |
Sirolimus and low-dose tacrolimus with antibody induction in kidney transplantation: preliminary results of a pilot study. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750382
|
Jiang H et al. |
Effect of FK 506 on heart allograft survival in highly sensitized recipient rats in comparison with cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1703702
|